Results 311 to 320 of about 412,466 (343)

The curing reactions of ethynyl-functional benzoxazine

Reactive and Functional Polymers, 2006
Abstract The model compounds 3-(3-ethynyl-phenyl)-6-methyl-3,4-dihydro-2H-benzoxazine (EPMB) and 6-methyl-3-phenyl-3,4-dihydro-2H-benzoxazine (PMB) were synthesized and the influence of ethynyl group on the thermal cure reaction of benzoxazine compound was investigated. The bond parameters of benzoxazine ring calculated at the level of B3LYP/6-31G(d)
Jianxiang Huang, Jian Zhang, Fan Wang, Farong Huang, Lei Du   +4 more
openaire   +1 more source

New treatments to reach functional cure: Virological approaches

Best Practice & Research Clinical Gastroenterology, 2017
Current therapies of chronic hepatitis B (CHB) remain limited to pegylated-interferon-alpha (pegIFN-α) or any of the five approved nucleos(t)ide analogues (NA). If viral suppression can be achieved in the majority of patients with the high-barrier-to-resistance new-generation of NA, i.e.
openaire   +2 more sources

UV curing of epoxy functional hybrid silicones

Journal of Applied Polymer Science, 2012
AbstractSeveral epoxy difunctional hybrid alkylene‐silicone telomers with different silicone characters and organic spacers (linkers) were prepared via the platinum‐catalyzed polyhydrosilylation of α,ω‐dihydrosiloxanes and α,ω‐dienes. Thereafter, the resulting SiH‐terminated prepolymers were terminally functionalized with 4‐vinyl‐1,2‐epoxycyclohexane ...
Sophie Putzien, Eckhart Louis, Oskar Nuyken, James V. Crivello, Fritz E. Kühn   +4 more
openaire   +1 more source

Biological basis for functional cure of chronic hepatitis B

Journal of Viral Hepatitis, 2019
SummaryChronic hepatitis B (CHB) infection affects over 250 millon people worldwide and 800000 are expected to die yearly due to the development of hepatocellular carcinoma (HCC). Current antiviral therapies include nucleoside analogs (NAs) that target the viral retrotranscriptase inhibiting de novo viral production.
Martinez, Maria, Testoni, Barbara, Zoulim, Fabien   +2 more
openaire   +2 more sources

CHAPTER 7. UV-Cured Functional Coatings

2014
UV-cured functional coatings ...
M. Sangermano, I. Roppolo, MESSORI, Massimo   +2 more
openaire   +1 more source

CRISPR as a functional cure for hemoglobinopathies

Ugeskrift for Læger
Severe haemoglobinopathies, including sickle cell disease and β-thalassaemia, represent significant global health burdens. CRISPR technology enables precise genetic editing of haematopoietic stem cells, with current therapies focused on boosting fetal haemoglobin production for a functional cure.
Andreas Glenthøj, Sarah Birgitte Ingemod Sand Carlsen, Marianne Hoffmann, Eva Kannik Haastrup, Lisbeth Pernille Andersen, Nina Toft, Brian Thomas Kornblit, Jesper Brix Petersen, Henrik Hasle, arianne Rosenkrantz Segelcke Ifversen   +9 more
openaire   +1 more source

Functionally Graded Adhesives Using Radiation Curing

AIAA Scitech 2020 Forum, 2020
Scott E. Stapleton, Alessandro G. Cassano, Sara Najafian, Daniel F. Schmidt   +3 more
openaire   +1 more source

Chimeric antigen receptor T‐cell therapy in multiple myeloma: A comprehensive review of current data and implications for clinical practice

Ca-A Cancer Journal for Clinicians, 2023
Rujul Parikh, Sagar Lonial
exaly  

[The expert consensus on clinical cure (functional cure) of chronic hepatitis B].

Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2019
Chronic hepatitis B virus (HBV) infection remains a major world public health problem. Current guidelines for the prevention and treatment of chronic hepatitis B (CHB) have suggested clinical cure (also known as functional cure) as the ideal therapeutic goal, which is associated with decreased risk of cirrhosis and hepatocellular carcinoma.
openaire   +1 more source

Prevention, treatment and cure of HIV infection

Nature Reviews Microbiology, 2023
Raphael J Landovitz, Hyman Scott, Steven G Deeks   +2 more
exaly